1 - VA-Related Infection (rate)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average rate of hemodialysis vascular access-related infection with IV antibiotic therapy among adult chronic HD patients
Type: Process
2 - VA-Related Infection (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of hemodialysis access-related infection among adult chronic HD patients with a clinically confirmed infection and prescribed IV antibiotics
Type: Process
3 - VA-Related Bacteremia (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of bacteremia among adult chronic HD patients with a hemodialysis access-related infection and prescribed IV antibiotics
Type: Process
4 - Utilization of High Ultrafiltration Rate for Fluid RemovalOrganization: Centers for Medicare & Medicaid Services
Description: The proportion of patients who did not receive an ultrafiltration (UF) rate greater than or equal to 15 mg/kg/hr in the reporting month.
Type: Process
5 - Utilization of Dialysis Duration of Four Hours or Longer for Patients New to DialysisOrganization: Centers for Medicare & Medicaid Services
Description: The proportion of patients new to hemodialysis (within the first 90 days since initiation of hemodialysis) whose delivered dialysis session length was at least 240 minutes.
Type: Process
6 - Use of Iron Therapy When IndicatedOrganization: Centers for Medicare and Medicaid Services
Description: Percentage of all adult (>= 18 years old) dialysis patients with a serum ferritin < 100ng/mL and a TSAT < 50% on at least one simultaneous measurement who received IV iron in the following three months.
Type: Process
7 - Unavailable Clinical Confirmation (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of “unavailable” information regarding clinical confirmation of infection among adult chronic HD patients with new IV antibiotic prescription
Type: Process
8 - Unavailable Blood Culture Results (percentage)Organization: Centers for Medicare and Medicaid Services
Description: Six-month rolling average prevalence of “unavailable” blood culture results for adult chronic HD patients with new IV antibiotic prescription
Type: Process
9 - Standardized Hospitalization Ratio for DaysOrganization: Centers for Medicare & Medicaid Services
Description: Risk-adjusted standardized hospitalization ratio for days for dialysis facility patients.
Type: Outcome
10 - Standardized Hospitalization Ratio for AdmissionsOrganization: Centers for Medicare & Medicaid Services
Description: Risk-adjusted standardized hospitalization ratio for admissions for dialysis facility patients.
Type: Outcome
11 - Sodium Profiling Practice for HemodialysisOrganization: Centers for Medicare & Medicaid Services
Description: The proportion of hemodialysis patients who were not prescribed sodium profiling in the reporting month.
Type: Process
12 - Restriction of Dialysate SodiumOrganization: Centers for Medicare & Medicaid Services
Description: The proportion of hemodialysis patients who were prescribed a dialysate sodium concentration less than or equal to 138 mEq/L in the reporting month.
Type: Process
13 - Proportion of patients with hypophosphatemiaOrganization: Centers for Medicare and Medicaid Services
Description: Proportion of patients with 3-month rolling average of serum phosphorus less than 2.5 mg/dL
Type: Outcome
14 - Proportion of patients with hypercalcemiaOrganization: Centers for Medicare and Medicaid Services
Description: Proportion of patients with 3-month rolling average of total uncorrected serum calcium greater than 10.2 mg/dL
Type: Outcome
15 - Periodic Assessment of Post-Dialysis Weight by NephrologistsOrganization: Centers for Medicare & Medicaid Services
Description: Proportion of patients who have documentation of receiving a new post-dialysis weight prescription from a nephrologist in the reporting month.
Type: Process
16 - Minimum target spKt/VOrganization: Centers for Medicare and Medicaid Services
Description: Percentage of all pediatric (<18 years old) in-center HD patients who have been on hemodialysis for 90 days or more and dialyzing 3 or 4 times weekly whose delivered dose of hemodialysis (calculated from the last measurements of the month using the UKM or Daugirdas II formula) was a spKt/V>= 1.2 during the reporting period
Type: Outcome
17 - Method of adequacy measurementOrganization: Centers for Medicare and Medicaid Services
Description: Percentage of pediatric (<18 years old) in-center HD patients (irrespective of frequency of dialysis) for whom delivered HD dose was measured by spKt/V as calculated using UKM or Daugirdas II during the reporting period
Type: Process
18 - Measurement of nPCROrganization: Centers for Medicare and Medicaid Services
Description: Percentage of pediatric (<18 years) in-center hemodialysis patients (irrespective of frequency of dialysis) with documented monthly nPCR measurements
Type: Process
19 - Lower limit of hemoglobinOrganization: Centers for Medicare and Medicaid Services
Description: Percentage of pediatric (<18 years old) hemodialysis and peritoneal dialysis patients, with ESRD >=3 months, who have a mean hemoglobin <10 g/dL for a 3 month reporting period, irrespective of ESA use. The hemoglobin value reported at the end of each reporting month (end-of-month hemoglobin) is used for the calculation.
Type: Outcome
20 - IV Antibiotic Therapy (rate)Organization: CMS
Description: CPM I- Six-month rolling average rate of initiating IV antibiotic prescription therapy for newly suspected infection among adult chronic HD patients
Type: Process
